ECCO CONFER Cases
COllaborative Network For Exceptionally Rare case reports
CONFER Cases Round 10 - Call for Similar Cases
ECCO CONFER is now opening the call for similar rare cases for the tenth Round of ECCO CONFER Cases.
Case 1:
Perianal Crohn's fistula in the absence of luminal disease - natural history, time to progression to luminal disease and management in contemporary clinical practice
Case 2:
Exposure to JAK-inhibitors during pregnancy and risk of adverse pregnancy outcome
Case 3:
Safety and efficacy of JAK inhibitors in patients with primary sclerosing cholangitis associated with inflammatory bowel disease.
For more information on the format and content criteria, as well as the selection process, please find the full call below.
ECCO CONFER Call for Similar Cases
Deadline for similar cases: March 15, 2024 - Submissions CLOSED.
Please respond to this call by sending your case to This email address is being protected from spambots. You need JavaScript enabled to view it..
Should you have any further questions, do not hesistate to call or contact the ECCO Office via email.
Please find below further information on the cases.
About
Unique and extraordinary clinical cases are generally reported in the form of a single case report or a small series, making it hard to derive clinical conclusions on modes of presentation, diagnosis, and treatment.
5 main themes of interest:
- Unusual clinical situations facing diagnostic or therapeutic gaps of knowledge
- Rare infections
- Uncommon drug beneficial effects or side-effects
- Rare IBD manifestations
- Infrequent disease associations (neoplastic, infectious etc.)
What is ECCO CONFER Cases?
The ECCO CONFER Cases are based on an initiative introduced by the European Crohn’s and Colitis Organisation (ECCO) to support individual investigators in developing rare case series by collecting enough similar cases among the IBD Community. By joining forces of the many members and supporters of ECCO, a joint report of all similar such cases can result in a large case series that will advance knowledge on these uncommon patients.
How it operates
A call will be made once a year to all ECCO Members to propose CONFER case projects. Two to four cases will be selected by the CONFER Steering Committee.
The proposing investigator will act as PI and develop his/her case into a CONFER case project with the support of a member of the CONFER Steering Committee.
A call will then be made to all ECCO Members and affiliates who have encountered a similar case to contribute their case to the CONFER case series.
All received cases will be joined into a case series by a PI and prepared for publication.
ECCO’s support:
ECCO’s support includes dissemination of a call for similar cases, as well as assessment of the feasibility of the cases by the ECCO CONFER Steering Committee. It does not include any financial support nor any input in the collection of the data, the analysis or the publication of the data collected.
Steering committee
ECCO CONFER is managed by a four-member steering committee. The current steering committee is composed of:
David Drobne (Slovenia)
Triana Lobaton (Belgium)
Mette Julsgaard (Denmark)
Daniela Pugliese (Italy)
Previous Rounds of CONFER Cases
CONFER Cases Round 9
Case 1: Treatment of chronic pouchitis with JAKs inhibitors and S1P receptor modulators
PI: Giulia Testa and Davide Ribaldone
Case Manager: Triana Lobaton
Manuscript published on JCC. DOI: 1093/ecco-jcc/jjad194
Case 3: Biologicals and/or small molecules in patients with microscopic colitis
PI: Bram Verstockt
Case Manager: Mette Julsgaard
Submitted as an abstract to the ECCO Congress 2024 and published on JCC with the title “Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort” (DOP79). DOI:1093/ecco-jcc/jjad212.0119
CONFER Cases Round 8
Case 1: IBD and hidradenitis suppurativa
PI: Bram Verstockt
Case Manager: Idan Goren
Hard copy poster at ECCO’23 and published on JCC, with the title “P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy: results from a real-life multicenter cohort”. DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0804
Case 2: Safety and efficacy of ustekinumab and vedolizumab after liver transplant for PSC-IBD patients
PI: Triana Lobaton
Case Manager: David Drobne
Published on JCC with the title: "P621 Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series", DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0751
Case 3: Solid organ transplant (but liver) in patients with inflammatory bowel disease
PI: Davide Ribaldone
Case Manager: Maria Chaparro
Hard copy poster at ECCO’23 and published on JCC with the title: “P252 Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series”. DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0382
CONFER Cases Round 7
Case 1: Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes
PI and Case Manager: Maria Chaparro
Hard copy poster at ECCO’22 and published on JCC with the title: "Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]". DOI: https://doi.org/10.1093/ecco-jcc/jjac050
Case 2: A patient with ulcerative colitis and immune thrombocytopenic purpura
PI: Hussein Mahajna
Case Manager: Uri Kopylov
Hard copy poster at ECCO’22 and published on JCC with the title: "Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series". DOI: https://doi.org/10.1093/ecco-jcc/jjac094
Case 3: Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases
PI: Brigida Barberio
Case Manager: Pierre Ellul
Hard copy poster at ECCO’22 and published on JCC with the title: "Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series". DOI: https://doi.org/10.1093/ecco-jcc/jjac094
Case 4: IBD and type 2 autoimmune pancreatitis - the diagnostic dilemmas. How far is from theory to clinical practice?
PI: Piotr Eder
Case Manager: Idan Goren
Hard copy poster at ECCO’22 and published on JCC with the title: "Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study". DOI: https://doi.org/10.1093/ecco-jcc/jjad097
CONFER Cases Round 6
Case 2: Neuroendocrine neoplasms in patients with IBD
PI: Giulia Zerboni and Stefano Festa
Case Manager: Idan Goren
Hard Copy Poster at ECCO’21 and published on JCC, with the title: "Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series". DOI: https://doi.org/10.1093/ecco-jcc/jjab217
Case 3: Primary Hypogammaglobulinaemia with IBD-like features
PI: Ahmad Albshesh
Case Manager: Uri Kopylov
DOP at ECCO’21 and published on JCC, with the title:"Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features"
DOI: https://doi.org/10.1093/ecco-jcc/jjab124